Schedule of Related Party Transactions |
Nature of relationships with related parties
Name of related parties | | Relationship with the Company | | | | Feng Zhou | | Major shareholder of the Company, Chief Executive Officer | Jun Zheng | | Director of the Company | Xiaodong Ji | | Independent Director of the Company | Taizhou Jiutian Pharmaceutical Co. Ltd. | | An entity controlled by Jianping Zhou | Jiangsu Health | | An entity controlled by Jianping Zhou | Taizhou Su Xuan Tang Chinese Medicine Clinic | | An entity controlled by Jianping Zhou | Taizhou Su Xuan Tang Chinese hospital Co., Ltd. | | An entity controlled by Jianping Zhou | Jiangsu Sutaitang Online Commercial Co., Ltd. | | An entity controlled by Xiaodong Ji | The amounts due from related parties as of March
31, 2025 and 2024 were as follows:
| |
As of March 31, | |
| |
2025 | | |
2024 | |
| |
| | |
| |
Jiangsu Sutaitang Online Commercial Co., Ltd. | |
$ | 370,862 | | |
$ | - | |
Taizhou Su Xuan Tang Chinese hospital Co., Ltd. | |
| 41,561 | | |
| - | |
Taizhou Su Xuan Tang Chinese Medicine Clinic | |
| 5,140 | | |
| - | |
Total due from related parties | |
$ | 417,563 | | |
$ | - | |
The amounts due to related parties as of March
31, 2025 and 2024 were as follows:
| |
As of March 31, | |
| |
2025 | | |
2024 | |
| |
| | |
| |
Jiangsu Health | |
$ | - | | |
$ | 1,047,550 | |
Total due to related parties | |
$ | - | | |
$ | 1,047,550 | |
These related party transactions were conducted
in the ordinary course of business of the Company.
| |
For the years ended March 31, | |
| |
2025 | | |
2024 | | |
2023 | |
| |
| | |
| | |
| |
Taizhou Su Xuan Tang Chinese Hospital Co. Ltd. | |
| 1,621 | | |
| 25,528 | | |
| 17,478 | |
Taizhou Su Xuan Tang Chinese Medicine Clinic | |
| 1,091 | | |
| 2,232 | | |
| 11,533 | |
Taizhou Jiutian Pharmaceutical Co. Ltd. | |
| 1,589 | | |
| - | | |
| 4,610 | |
Total revenue generated from related parties | |
$ | 4,301 | | |
$ | 27,760 | | |
$ | 33,621 | |
|